Abstract:Rationale: Mitochondria are important cellular organelles and play essential roles in maintaining cell structure and function. Emerging evidence indicates that in addition to having proinflammatory and proapoptotic effects, TNFα (tumor necrosis factor α) can, under certain circumstances, promote improvements in mitochondrial integrity and function, phenomena that can be ascribed to the existence of TNFR2 (TNFα receptor 2). Objective: The present study aimed to investigate whether and how TNFR2 activation mediates the effects of TNFα on mitochondria. Methods and Results: Freshly isolated neonatal mouse cardiac myocytes treated with shRNA targeting TNFR1 were used to study the effects of TNFR2 activation on mitochondrial function. Neonatal mouse cardiac myocytes exhibited increases in mitochondrial fusion, a change that was associated with increases in mitochondrial membrane potential, intracellular ATP levels, and oxygen consumption capacity. Importantly, TNFR2 activation–induced increases in OPA1 (optic atrophy 1) protein expression were responsible for the above enhancements, and these changes could be attenuated using siRNA targeting OPA1. Moreover, both Stat3 and RelA bound to the promoter region of OPA1 and their interactions synergistically upregulated OPA1 expression at the transcriptional level. Stat3 acetylation at lysine 370 or lysine 383 played a key role in the ability of Stat3 to form a supercomplex with RelA. Meanwhile, p300 modulated Stat3 acetylation in HEK293T (human embryonic kidney 293T) cells, and p300-mediated Stat3/RelA interactions played an indispensable role in OPA1 upregulation. Finally, TNFR2 activation exerted beneficial effects on OPA1 expression in an in vivo transverse aortic constriction model, whereby TNFR1-knockout mice exhibited better outcomes than in mice with both TNFR1 and TNFR2 knocked out. Conclusions: TNFR2 activation protects cardiac myocytes against stress by upregulating OPA1 expression. This process was facilitated by p300-mediated Stat3 acetylation and Stat3/RelA interactions, leading to improvements in mitochondrial morphology and function.

Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin

Deregulation of Mitochondrial Fusion and Fission in Neurodegenerative Diseases

and disease-causing mutants perturb mitochondrial nucleoid distribution

OPA1 and disease-causing mutants perturb mitochondrial nucleoid distribution

Structural Insights into G Domain Dimerization and Pathogenic Mutation of OPA1.

Identification of SLC25A46 interaction interfaces with mitochondrial membrane fusogens Opa1 and Mfn2

Bringing together but staying apart: decisive differences in animal and fungal mitochondrial inner membrane fusion

The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission

TNFR 2 Stimulation Promotes Mitochondrial Fusion Via Stat 3-and NF-kB – Dependent Activation of OPA 1 Expression

Lipidomics reveals the reshaping of the mitochondrial phospholipid profile in cells lacking OPA1 and mitofusins

Modulating mitofusins to control mitochondrial function and signaling

Mitochondrial OMA1 and OPA1 as Gatekeepers of Organellar Structure/Function and Cellular Stress Response

Mitochondrial membrane potential and oxidative stress interact to regulate Oma1-dependent processing of Opa1 and mitochondrial dynamics

In situ architecture of Opa1-dependent mitochondrial cristae remodeling

Molecular mechanisms of mitochondrial dynamics

Cardiolipin clustering promotes mitochondrial membrane dynamics

A review for the correlation between optic atrophy 1-dependent mitochondrial fusion and cardiovascular disorders

OMA1-Mediated Mitochondrial Dynamics Balance Organellar Homeostasis Upstream of Cellular Stress Responses

Mitofusin-mediated contacts between mitochondria and peroxisomes regulate mitochondrial fusion

OPA1 and MICOS Regulate Mitochondrial Crista Dynamics and Formation.

The mitochondrial inner membrane protein mitofilin controls cristae morphology.